Oak Street Health Inc

Oak Street Health Inc

  • Price (EUR)17.40
  • Today's Change-0.50 / -2.79%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jan 20 2022 07:02 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Oak Street Health, Inc. is a holding company. The Company, through its subsidiaries, operates primary care centers serving Medicare beneficiaries. The Company, through its centers and management services organization, combines a care model with patient experience. It offers RubiconMD, a technology platform which provides access to specialists. It provides clinical insights from specialists on specific patient cases, enabling primary care providers to directly manage and coordinate more of a patient’s care needs. Its specialties include Cardiology, Nephrology and Pulmonology. The Company’s subsidiaries include Oak Street Health MSO, LLC., which operates as a management services organization and is in the business of providing management and other administrative services to its physician practice organizations.

  • Revenue in USD (TTM)1.29bn
  • Net income in USD-357.81m
  • Incorporated--
  • Employees3.20k
  • Location
    Oak Street Health Inc30 W. Monroe St., Ste. 1200CHICAGO 60603United StatesUSA
  • Phone+1 (312) 773-3374
  • Fax+1 (302) 655-5049
  • Websitehttps://www.oakstreethealth.com
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
OSH:NYQ since
RubiconMD IncDeal completed20 Oct 202120 Oct 2021Deal completed-53.80%130.00m
Data delayed at least 15 minutes, as of Jan 19 2022 21:10 GMT.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.